The post Pancreatic Cancer Vaccine Shows Potential in Early Trial appeared first on Reason.com.

But sometimes life throws us curveballs, like a major health issue. It's no fun to navigate treatment for cancer or other ...

NovoCure remains a strong buy with robust earnings, growth in cancer treatments, and significant upside potential to Wall ...

The FDA granted RMAT designation to nogapendekin alfa and CAR-NK for reversing lymphopenia in patients with cancer, with ...

A rapid nanosensor assay that measures serum protease cleavage of a target-probe nanosensor can identify pancreatic ductal ...

ImmunityBio shares advanced 17% to $3.34 after the company said the Food and Drug Administration awarded a regenerative medicine advanced therapy designation for Anktiva and CAR-NK for the reversal of ...

BATON ROUGE, La. (WAFB) - Southern football safeties coach and former star player, Sean Wallace will be laid to rest Friday, Feb. 28. He was 52 when he passed away.

Alpharetta Detective Brian Smith spent more than 19 years serving his community. He passed away this week after a battle with ...

Iowa's annual cancer report shows a troubling trend. What's making this year stand out and the concerns one cancer survivor ...

Half of all pancreatic cancer patients live less than a year after diagnosis. But researchers say there is potential for ...

NovoCure's FDA approvals face adoption struggles despite growth. Read why NVCR stock may decline with slow indication ...

The group recently published a case-control study showing high sensitivity and specificity, with little drop in early-stage disease, compared to late-stage cancer.